Literature DB >> 12681992

Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.

Giuseppe Visani, Pier Paolo Piccaluga, Giovanni Martinelli, Maura Rossi, Michele Malagola, Michele Baccarani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12681992

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

1.  All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Authors:  Zhi-Xiang Shen; Zhan-Zhong Shi; Jing Fang; Bai-Wei Gu; Jun-Min Li; Yong-Mei Zhu; Jing-Yi Shi; Pei-Zheng Zheng; Hua Yan; Yuan-Fang Liu; Yu Chen; Yang Shen; Wen Wu; Wei Tang; Samuel Waxman; Hugues De Thé; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

2.  The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome.

Authors:  Adil S A Al Hinai; Marta Pratcorona; Tim Grob; François G Kavelaars; Elena Bussaglia; Mathijs A Sanders; Josep Nomdedeu; Peter J M Valk
Journal:  Hemasphere       Date:  2019-03-05

Review 3.  Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

Authors:  Guilherme Augusto Dos Santos; Lev Kats; Pier Paolo Pandolfi
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.